Among the most urgent worldwide health issues we currently confront is antimicrobial resistance (AMR). The efficacy of modern medical therapies reduces as germs change and grow resistant to current medications. This concerning tendency seriously compromises public health systems all around as well as individual patients. By offering sophisticated t

As Microsoft and OpenAI sign a $13 billion AI bot agreement, tech is vibrating with excitement and tension. This massive cooperation will transform how businesses and consumers use technology by harnessing AI. Despite the hoopla, an EU antitrust inquiry could change this ambitious venture. The consequences of such a huge collaboration raise market

As Microsoft and OpenAI sign a $13 billion AI bot agreement, tech is vibrating with excitement and tension. This massive cooperation will transform how businesses and consumers use technology by harnessing AI. Despite the hoopla, an EU antitrust inquiry could change this ambitious venture. The consequences of such a huge collaboration raise market

As Microsoft and OpenAI sign a $13 billion AI bot agreement, tech is vibrating with excitement and tension. This massive cooperation will transform how businesses and consumers use technology by harnessing AI. Despite the hoopla, an EU antitrust inquiry could change this ambitious venture. The consequences of such a huge collaboration raise market

As Microsoft and OpenAI sign a $13 billion AI bot agreement, tech is vibrating with excitement and tension. This massive cooperation will transform how businesses and consumers use technology by harnessing AI. Despite the hoopla, an EU antitrust inquiry could change this ambitious venture. The consequences of such a huge collaboration raise market